Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Ivarmacitinib in alopecia areata
NCT04346316Phase 2Completed
- Sponsor
- Reistone Biopharma
- Start
- May 2020
- Primary completion
- Jun 2021
- Modality
- Small Molecules
- Countries
- 3
01
Overview
A Phase 2 trial of ivarmacitinib in alopecia areata, sponsored by Reistone Biopharma. Started May 2020; status: completed.
02
Drugs
ivarmacitinib
03
Conditions
alopecia areata
Beyond the preview
Go deeper on NCT04346316.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04346316.